原贵阳医学院副院长王小林受贿超1.5亿元被判死缓，信邦制药卷入

Company Dynamics - Wang Xiaolin, former Vice President of Guiyang Medical College and President of its affiliated hospital, was sentenced to death with a two-year reprieve for bribery, with a total of over 150 million RMB received illegally from 2002 to 2023 [2] - The court found that Wang's actions had severe social impacts and warranted strict punishment, although mitigating factors such as partial restitution and confession were considered [2] Related Company Information - Xinpang Pharmaceutical, founded by alumni of Guiyang Medical College, became the first listed company in Qiannan Prefecture in 2010 and has developed into a leading pharmaceutical distribution enterprise in Guizhou Province [3] - In 2023, the subsidiary Keke Pharmaceutical reported revenues of 2.278 billion RMB and a net profit of 94.5 million RMB, accounting for 35.26% and 26.71% of Xinpang Pharmaceutical's respective figures [3] - Legal issues arose when Keke Pharmaceutical was involved in a bribery case linked to Wang Xiaolin, with the company stating that the ongoing litigation is not expected to significantly impact profits, although the exact effects remain uncertain [4]